• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤科健康状态效用评估:皮肤病生活质量指数的实验时间权衡值集。

Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index.

机构信息

Department of Statistics, Corvinus University of Budapest, 8 Fővám tér, 1093, Budapest, Hungary.

Doctoral School of Psychology, Institute of Psychology, Eötvös Loránd University, 46 Izabella u., 1064, Budapest, Hungary.

出版信息

Health Qual Life Outcomes. 2022 Jun 3;20(1):87. doi: 10.1186/s12955-022-01995-x.

DOI:10.1186/s12955-022-01995-x
PMID:35658979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9164408/
Abstract

BACKGROUND

Dermatology Life Quality Index (DLQI) scores are used in many countries as access and reimbursement criteria for costly dermatological treatments. In this study we examined how time trade-off (TTO) utility valuations made by individuals from the general population are related to combinations of DLQI severity levels characterizing dermatologically relevant health states, with the ultimate purpose of developing a value set for the DLQI.

METHODS

We used data from an online cross-sectional survey conducted in Hungary in 2020 (n = 842 after sample exclusions). Respondents were assigned to one of 18 random blocks and were asked to provide 10-year TTO valuations for the corresponding five hypothetical health states. To analyze the relationship between DLQI severity levels and utility valuations, we estimated linear, censored, ordinal, and beta regression models, complemented by two-part scalable models accommodating heterogeneity effects in respondents' valuation scale usage. Successive severity levels (0-3) of each DLQI item were represented by dummy variables. We used cross-validation methods to reduce the initial set of 30 dummy variables and improve model robustness.

RESULTS

Our final, censored linear regression model with 13 dummy variables had R = 0.136, thus accounting for 36.9% of the incremental explanatory power of a maximal (full-information) benchmark model (R = 0.148) over the uni-dimensional model (R = 0.129). Each DLQI item was found to have a negative effect on the valuation of health states, yet this effect was largely heterogeneous across DLQI items, and the relative contribution of distinctive severity levels also varied substantially. Overall, we found that the social/interpersonal consequences of skin conditions (in the areas of social and leisure activities, work and school, close personal relationships, and sexuality) had roughly twice as large disutility impact as the physical/practical aspects.

CONCLUSIONS

We have developed an experimental value set for the DLQI, which could prospectively be used for quantifying the quality-adjusted life years impact of dermatological treatments and serve as a basis for cost-effectiveness analyses. We suggest that, after validation of our main results through confirmatory studies, population-specific DLQI value sets could be developed and used for conducting cost-effectiveness analyses and developing financing guidelines in dermatological care.

摘要

背景

皮肤病生活质量指数(DLQI)评分被许多国家用作昂贵皮肤病治疗的准入和报销标准。本研究旨在探讨一般人群的时间权衡(TTO)效用评估与描述皮肤病相关健康状况的 DLQI 严重程度水平的组合之间的关系,最终目的是为 DLQI 制定一个价值体系。

方法

我们使用了 2020 年在匈牙利进行的一项在线横断面调查的数据(经样本排除后为 842 名参与者)。受访者被分配到 18 个随机块中的一个,并被要求对相应的 5 个假设健康状态提供 10 年 TTO 估值。为了分析 DLQI 严重程度水平与效用评估之间的关系,我们估计了线性、删失、有序和贝塔回归模型,并补充了两部分可扩展模型,以适应受访者估值量表使用中的异质性效应。每个 DLQI 项目的连续严重程度(0-3)由虚拟变量表示。我们使用交叉验证方法来减少初始的 30 个虚拟变量集,并提高模型的稳健性。

结果

我们最终的删失线性回归模型有 13 个虚拟变量,R²为 0.136,因此比最大(完全信息)基准模型(R²为 0.148)对单一维度模型(R²为 0.129)的增量解释能力高出 36.9%。每个 DLQI 项目都对健康状态的估值产生负面影响,但这种影响在 DLQI 项目之间存在很大的异质性,不同特征严重程度的相对贡献也有很大差异。总的来说,我们发现皮肤状况的社会/人际关系后果(社交和休闲活动、工作和学校、亲密人际关系和性)的不舒适影响大约是身体/实际方面的两倍。

结论

我们已经为 DLQI 制定了一个实验价值体系,该体系可用于前瞻性地量化皮肤病治疗的质量调整生命年影响,并作为成本效益分析的基础。我们建议,在通过验证性研究验证我们的主要结果后,可以开发针对特定人群的 DLQI 价值体系,并将其用于进行成本效益分析和制定皮肤病护理的融资指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/e73768dea72e/12955_2022_1995_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/77a853c3628d/12955_2022_1995_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/87593ddf83f7/12955_2022_1995_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/7c35aa073af4/12955_2022_1995_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/2b780fbb263d/12955_2022_1995_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/ba2381f11f08/12955_2022_1995_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/8e1c91e89f71/12955_2022_1995_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/df22e57bdef4/12955_2022_1995_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/e73768dea72e/12955_2022_1995_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/77a853c3628d/12955_2022_1995_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/87593ddf83f7/12955_2022_1995_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/7c35aa073af4/12955_2022_1995_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/2b780fbb263d/12955_2022_1995_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/ba2381f11f08/12955_2022_1995_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/8e1c91e89f71/12955_2022_1995_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/df22e57bdef4/12955_2022_1995_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/9164408/e73768dea72e/12955_2022_1995_Fig8_HTML.jpg

相似文献

1
Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index.皮肤科健康状态效用评估:皮肤病生活质量指数的实验时间权衡值集。
Health Qual Life Outcomes. 2022 Jun 3;20(1):87. doi: 10.1186/s12955-022-01995-x.
2
Discrepancies between the Dermatology Life Quality Index and utility scores.皮肤病生活质量指数与效用评分之间的差异。
Qual Life Res. 2016 Jul;25(7):1687-96. doi: 10.1007/s11136-015-1208-z. Epub 2015 Dec 18.
3
Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.基于经验的瑞典 TTO 和 EQ-5D-5L 健康状态下的 VAS 值集。
Pharmacoeconomics. 2020 Aug;38(8):839-856. doi: 10.1007/s40273-020-00905-7.
4
Is the DLQI appropriate for medical decision-making in psoriasis patients?DLQI 是否适用于银屑病患者的医学决策?
Arch Dermatol Res. 2018 Jan;310(1):47-55. doi: 10.1007/s00403-017-1794-4. Epub 2017 Nov 11.
5
A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16.皮肤病生活质量指数(DLQI)、DLQI 相关和 Skindex-16 的测量特性比较研究。
Br J Dermatol. 2022 Mar;186(3):485-495. doi: 10.1111/bjd.20765. Epub 2021 Nov 24.
6
DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.DLQI-R评分提高了皮肤病生活质量指数对银屑病、天疱疮和硬斑病患者的鉴别能力。
Br J Dermatol. 2020 May;182(5):1167-1175. doi: 10.1111/bjd.18435. Epub 2019 Oct 16.
7
Normative data and socio-demographic determinants of the dermatology life quality index in a large online sample of the Hungarian population.在匈牙利人群的一个大型在线样本中,皮肤病生活质量指数的规范数据和社会人口统计学决定因素。
Expert Rev Pharmacoecon Outcomes Res. 2022 Oct;22(7):1153-1161. doi: 10.1080/14737167.2022.2108793. Epub 2022 Aug 8.
8
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.探讨 EQ-5D、DLQI 和 PASI 之间的关系,并对 EQ-5D 效用进行映射:来自匈牙利的银屑病横断面研究。
Eur J Health Econ. 2014 May;15 Suppl 1:S111-9. doi: 10.1007/s10198-014-0600-x. Epub 2014 May 16.
9
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.比较三种欧洲国家用 EQ-5D 衡量的人口健康状况的不同评估方法。
Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.
10
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.从皮肤病生活质量指数生成 EQ-5D-3L 效用评分:一项针对银屑病患者的映射研究。
Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.

引用本文的文献

1
Predicting EQ-5D-3L utility values from clinical data in a prospective cohort of kidney transplant recipients.在前瞻性肾移植受者队列中根据临床数据预测EQ-5D-3L效用值。
Eur J Health Econ. 2025 Jun 11. doi: 10.1007/s10198-025-01802-6.
2
Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis.特应性皮炎、化脓性汗腺炎、天疱疮和银屑病患者健康相关生活质量的比较。
Arch Dermatol Res. 2025 Jan 18;317(1):291. doi: 10.1007/s00403-024-03786-4.
3
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases.

本文引用的文献

1
Questionnaire Modifications and Alternative Scoring Methods of the Dermatology Life Quality Index: A Systematic Review.皮肤病生活质量指数的问卷修订和替代评分方法:系统评价。
Value Health. 2021 Aug;24(8):1158-1171. doi: 10.1016/j.jval.2021.02.006. Epub 2021 Apr 21.
2
Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off.运用复合时间权衡法比较 EQ-5D-5L 的线上和面对面估值。
Qual Life Res. 2021 May;30(5):1433-1444. doi: 10.1007/s11136-020-02712-1. Epub 2020 Nov 28.
3
Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
比较慢性皮肤病患者的EQ-5D-5L、PROPr、SF-6D和TTO效用值。
Eur J Health Econ. 2025 Jun;26(4):627-639. doi: 10.1007/s10198-024-01728-5. Epub 2024 Sep 28.
EQ-5D-5L、Skindex-16、DLQI和DLQI-R在化脓性汗腺炎患者中的效度。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2584-2592. doi: 10.1111/jdv.16642. Epub 2020 Jul 2.
4
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.从皮肤病生活质量指数生成 EQ-5D-3L 效用评分:一项针对银屑病患者的映射研究。
Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.
5
Association between quality of life and clinical characteristics in patients with morphea.硬斑病患者生活质量与临床特征的相关性研究。
Qual Life Res. 2018 Oct;27(10):2525-2532. doi: 10.1007/s11136-018-1897-1. Epub 2018 Jun 19.
6
Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus.寻常型天疱疮和落叶型天疱疮患者的 EQ-5D 量表的有效性。
Br J Dermatol. 2019 Apr;180(4):802-809. doi: 10.1111/bjd.16883. Epub 2018 Sep 19.
7
Is the DLQI appropriate for medical decision-making in psoriasis patients?DLQI 是否适用于银屑病患者的医学决策?
Arch Dermatol Res. 2018 Jan;310(1):47-55. doi: 10.1007/s00403-017-1794-4. Epub 2017 Nov 11.
8
A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.对银屑病 DLQI 中“不相关”回答的详细分析:治疗决策中的潜在偏差。
J Eur Acad Dermatol Venereol. 2018 May;32(5):783-790. doi: 10.1111/jdv.14676. Epub 2017 Nov 28.
9
The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.条件特异性偏好测量在卫生技术评估中的作用。
Pharmacoeconomics. 2017 Dec;35(Suppl 1):33-41. doi: 10.1007/s40273-017-0546-9.
10
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models.基于通用偏好的措施在成本效益模型中的应用综述。
Pharmacoeconomics. 2017 Dec;35(Suppl 1):21-31. doi: 10.1007/s40273-017-0545-x.